The exchangeable calcium pool: Physiology and pathophysiology in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2438-2444

  Pirklbauer, Markus ^a   Mayer, Gert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

; calcium homeostasis; chronic kidney disease; CKD; exchangeable calcium pool; extraosseous calcification; MBD

Indexed keywords

CALCIUM ION; OSTEOCALCIN; OSTEONECTIN; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT;

BLOOD VESSEL CALCIFICATION; BONE DISEASE; BONE MINERALIZATION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; HEMODIALYSIS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REVIEW; SOFT TISSUE CALCIFICATION; STEADY STATE;

ANIMALS; CALCIUM; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 79961088793     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr207     Document Type: Review

References (75)

1. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483 (Pubitemid 30318271)
2. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009;76:S1-S130
3. Barreto DV, Barreto Fde C, Carvalho AB et al. Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis 2008;52:1139-1150
4. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218 (Pubitemid 39031360)
5. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252 (Pubitemid 34754068)
6. Qunibi W, Moustafa M, Muenz LR et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008;51:952-965 (Pubitemid 351697566)
7. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 2004;19(Suppl 5):V59-V66 (Pubitemid 39214202)
8. Covic A, Kanbay M, Voroneanu L et al. Vascular calcification in chronic kidney disease. Clin Sci (Lond) 2010;119:111-121
9. Kerr PG, Guerin AP. Arterial calcification and stiffness in chronic kidney disease. Clin Exp Pharmacol Physiol 2007;34:683-687 (Pubitemid 46953119)
10. Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N et al. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 2006;17:S267-S273 (Pubitemid 44865260)
11. London GM, Marchais SJ, Guerin AP et al. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 2005;14:525-531 (Pubitemid 41531842)
12. Rothe H, Mayer G, Eller P et al. Genetic make-up of calcium-sensing receptor polymorphic position 990 and parameters of secondary hyperparathyroidism in haemodialysis centres from New York and Innsbruck [Abstract]. Nephrol Dial Transplant 2007;22:191
13. Brown EM, Gamba G, Riccardi D et al. Cloning and characterization of an extracellular Ca (2+)-sensing receptor from bovine parathyroid. Nature 1993;366:575-580 (Pubitemid 24035999)
14. Goodman WG, Quarles LD. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney Int 2008;74:276-288 (Pubitemid 352001233)
15. Bronner F, Stein WD. Calcium homeostasis-an old problem revisited. J Nutr 1995;125:1987-1995
16. Houillier P, Froissart M, Maruani G et al. What serum calcium can tell us and what it can't. Nephrol Dial Transplant 2006;21:29-32 (Pubitemid 43057104)
17. Bushinsky DA. Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content. Clin J Am Soc Nephrol 2010;5(Suppl 1):S12-S22
18. Nordin BE, Morris HA, Horowitz M et al. Calcium malabsorption does not cause secondary hyperparathyroidism. Calcif Tissue Int 2009;85:31-36
19. Lewin E, Wang W, Olgaard K. Rapid recovery of plasma ionized calcium after acute induction of hypocalcaemia in parathyroidectomized and nephrectomized rats. Nephrol Dial Transplant 1999;14:604-609 (Pubitemid 29105985)
20. Kotchen TA, Mauli KI, Luke R et al. Effect of acute and chronic calcium administration on plasma renin. J Clin Invest 1974;54:1279-1286
21. Jara A, Lee E, Stauber D et al. Phosphate depletion in the rat: effect of bisphosphonates and the calcemic response to PTH. Kidney Int 1999;55:1434-1443 (Pubitemid 29157142)
22. Landman JO, Schweitzer DH, Frolich M et al. Recovery of serum calcium concentrations following acute hypocalcemia in patients with osteoporosis on long-term oral therapy with the bisphosphonate pamidronate. J Clin Endocrinol Metab 1995;80:524-528
23. Heaney RP. How does bone support calcium homeostasis? Bone 2003;33:264-268 (Pubitemid 37103242)
24. Wang W, Lewin E, Olgaard K. Parathyroid hormone is not a key hormone in the rapid minute-to-minute regulation of plasma Ca2+ homeostasis in rats. Eur J Clin Invest 1999;29:309-320 (Pubitemid 29188824)
25. Albright F, Bauer W, Ropes M et al. Studies of calcium and phosphorus metabolism: IV. The effect of the parathyroid hormone. J Clin Invest 1929;7:139-181
26. Parsons JA, Neer RM, Potts JT Jr. Initial fall of plasma calcium after intravenous injection of parathyroid hormone. Endocrinology 1971;89:735-740
27. Roodman GD. Advances in bone biology: the osteoclast. Endocr Rev 1996;17:308-332 (Pubitemid 26277978)
28. Marenzana M, Shipley AM, Squitiero P et al. Bone as an ion exchange organ: evidence for instantaneous cell-dependent calcium efflux from bone not due to resorption. Bone 2005;37:545-554 (Pubitemid 41317327)
29. Parfitt AM. Misconceptions (3): calcium leaves bone only by resorption and enters only by formation. Bone 2003;33:259-263 (Pubitemid 37103241)
30. Talmage RV, Mobley HT. The concentration of free calcium in plasma is set by the extracellular action of noncollagenous proteins and hydroxyapatite. Gen Comp Endocrinol 2009;162:245-250
31. Ray RD. Circulation and bone. In: Bourne GH (ed). The Biochemistry and Physiology of Bone, 2nd edn, Vol. IV. New York: Academic Press, 1976, pp. 385-402.
32. Gotch F, Kotanko P, Handelman G et al. A kinetic model of calcium mass balance during dialysis therapy. Blood Purif 2007;25:139-149 (Pubitemid 46005766)
33. Barnas U, Schmidt A, Seidl G et al. A comparison of quantitative computed tomography and dual X-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis. Am J Kidney Dis 2001;37:1247-1252 (Pubitemid 32525162)
34. Hou SH, Zhao J, Ellman CF et al. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis 1991;18:217-224
35. Neuman WF. Aerobic glycolysis in bone in the context of membranecompartmentalization. Calcif Tissue Res 1977;22(Suppl):169-178
36. Bertazzo S, Zambuzzi WF, Campos DD et al. Hydroxyapatite surface solubility and effect on cell adhesion. Colloids Surf B Biointerfaces 2010;78:177-184
37. Parfitt AM. Calcium homeostasis. In: Mundy GR, Martin TJ (eds). Physiology and Pharmacology of bone. Handbook Exp Pharm, vol. 107, Berlin: Springer, 1993, pp. 1-65.
38. Kaye M. Hypocalcemia after an acute phosphate load is secondary to reduced calcium efflux from bone: studies in patients with minimal renal function and varying parathyroid activity. J Am Soc Nephrol 1995;6:273-280
39. Roufosse AH, Landis WJ, Sabine WK et al. Identification of brushite in newly deposited bone mineral from embryonic chicks. J Ultrastruct Res 1979;68:235-255 (Pubitemid 10201353)
40. Neuman WF, Neuman MW, Diamond AG et al. Blood:bone disequilibrium. VI. Studies of the solubility characteristics of brushite: apatite mixtures and their stabilization by noncollagenous proteins of bone. Calcif Tissue Int 1982;34:149-157 (Pubitemid 12128642)
41. Malsy A, Bohner M. Brushite conversion into apatite [Abstract]. European Cells and Materials 2005;10(Suppl 1):28
42. Roach HI. Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption. Cell Biol Int 1994;18:617-628 (Pubitemid 24239837)
43. Menanteau J, Neuman WF, Neuman MW. A study of bone proteins which can prevent hydroxyapatite formation. Metab Bone Dis Relat Res 1982;4:157-162
44. Neuman MW. Blood:bone equilibrium. Calcif Tissue Int 1982;34:117-120
45. Bini A, Mann KG, Kudryk BJ et al. Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1852-1861 (Pubitemid 29379914)
46. Young MF, Day AA, Dominquez P et al. Structure and expression of osteonectin mRNA in human tissue. Connect Tissue Res 1990;24:17-28
47. Hauschka PV, Lian JB, Cole DE et al. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990-1047 (Pubitemid 19184853)
48. Hoang QQ, Sicheri F, Howard AJ et al. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 2003;425:977-980 (Pubitemid 37376930)
49. Ducy P, Desbois C, Boyce B et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-452 (Pubitemid 26264860)
50. Kerner SA, Scott RA, Pike JW. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci U S A 1989;86:4455-4459 (Pubitemid 19164573)
51. Schule R, Umesono K, Mangelsdorf DJ et al. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 1990;61:497-504
52. Li YP, Stashenko P. Characterization of a tumor necrosis factorresponsive element which down-regulates the human osteocalcin gene. Mol Cell Biol 1993;13:3714-3721 (Pubitemid 23157308)
53. Schedlich LJ, Flanagan JL, Crofts LA et al. Transcriptional activation of the human osteocalcin gene by basic fibroblast growth factor. J Bone Miner Res 1994;9:143-152 (Pubitemid 24041559)
54. Morrison NA, Shine J, Fragonas JC et al. 1, 25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 1989;246:1158-1161 (Pubitemid 20012774)
55. Wolf G. Function of the bone protein osteocalcin: definitive evidence. Nutr Rev 1996;54:332-333 (Pubitemid 27129677)
56. Yagami K, Suh JY, Enomoto-Iwamoto M et al. Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 1999;147:1097-1108
57. Francucci CM, Ceccoli L, Rilli S et al. Skeletal effects of oral anticoagulants. J Endocrinol Invest 2009;32:27-31
58. Krueger T, Westenfeld R, Schurgers L et al. Coagulation meets calcification: the vitamin K system. Int J Artif Organs 2009;32:67-74
59. Kaji H. Pyrophosphate and mineralization (TNSALP, PC-1, ANK). Clin Calcium 2007;17:1574-1579
60. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010;7:528-536
61. Robertson WG, Morgan DB. Effect of pyrophosphate on the exchangeable calcium pool of hydroxyapatite crystals. Biochim Biophys Acta 1971;230:495-503
62. Eller P, Hochegger K, Feuchtner GM et al. Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure. Nephrol Dial Transplant 2008;23:321-327 (Pubitemid 351767378)
63. Raisz LG, Niemann I. Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology 1969;85:446-452
64. Roy ME, Nishimoto SK. Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 2002;31:296-302 (Pubitemid 34814964)
65. Bushinsky DA, Lechleider RJ. Mechanism of proton-induced bone calcium release: calcium carbonate-dissolution. Am J Physiol 1987;253:F998-1005
66. Urban E, Beck N, Reineck HJ et al. Calcium metabolism in young rats during early dietary phosphate deprivation. J Pediatr Gastroenterol Nutr 1982;1:437-443 (Pubitemid 13247141)
67. Neuman MW, Neuman WF. On the measurement of water compartments, pH, and gradients in calvaria. Calcif Tissue Int 1980;31:135-145 (Pubitemid 10061144)
68. Bushinsky DA, Wolbach W, Sessler NE et al. Physicochemical effects of acidosis on bone calcium flux and surface ion composition. J Bone Miner Res 1993;8:93-102 (Pubitemid 23034000)
69. Pahl M, Jara A, Bover J et al. Studies in a hemodialysis patient indicating that calcitriol may have a direct suppressive effect on bone. Nephron 1995;71:218-223
70. Pinto MR, Gorski JP, Penniston JT et al. Age-related changes in composition and Ca2+-binding capacity of canine cortical bone extracts. Am J Physiol 1988;255:101-110
71. Kurz P, Monier-Faugere MC, Bognar B et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994;46:855-861 (Pubitemid 24272045)
72. London GM, Marchais SJ, Guerin AP et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008;19:1827-1835
73. Seeman E. Evidence that calcium supplements reduce fracture risk is lacking. Clin J Am Soc Nephrol 2010;5(Suppl 1):S3-11
74. Reid IR, Bolland MJ, Grey A. Effect of calcium supplementation on hip fractures. Osteoporos Int 2008;19:1119-1123
75. Karohl C, de Paiva Paschoal J, de Castro MC et al. Effects of bone remodelling on calcium mass transfer during haemodialysis. Nephrol Dial Transplant 2010;25:1244-1251